Douglas Stamp, PA
Medical · Bremerton, WANPI 1083663025
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,585 of the $5,350 with a category attached, or 85.7%. It is spread thinly across 30 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 194 payments — averaging $27.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Nalu Medical, Inc.$632
- SPR Therapeutics, Inc$486
- Collegium Pharmaceutical, Inc.$431
- Tersera Therapeutics LLC$303
- Boston Scientific$289
- plus $2K from 24 others
What the payments were for
- Travel & lodging$58811%
- Food & beverage$4,58586%
- Education$1773%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 67 | $1,242 |
| Nalu Medical, Inc. | 3 | $632 |
| SPR Therapeutics, Inc | 1 | $486 |
| Collegium Pharmaceutical, Inc. | 26 | $431 |
| Tersera Therapeutics LLC | 6 | $303 |
| Boston Scientific | 11 | $289 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $287 |
| Saluda Medical Americas, Inc. | 2 | $276 |
| Virtus Pharmaceuticals LLC | 7 | $145 |
| Pfizer | 7 | $142 |
| Medtronic | 4 | $113 |
| Nevro Corp. | 4 | $104 |
| Invictus Surgical Incorporated | 2 | $99 |
| Amgen(2 entities) | 4 | $85 |
| Scilex Pharmaceuticals Inc. | 5 | $79 |
| Teva Pharmaceuticals USA, Inc. | 3 | $77 |
| Lilly USA, LLC | 4 | $74 |
| Relievant Medsystems, Inc. | 3 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $65 |
| GRT US Holding, Inc. | 3 | $58 |
| Vertex | 2 | $42 |
| Azurity Pharmaceuticals, Inc. | 2 | $40 |
| Redhill Biopharma Inc. | 2 | $38 |
| Piramal Critical Care | 2 | $36 |
| Biotronik NRO, Inc. | 1 | $29 |
| Averitas Pharma Inc. | 1 | $29 |
| Siemens Medical Solutions USA, Inc. | 1 | $27 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Globus Medical | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,350 in reported general payments places this provider in the 90th percentile of 457 medical providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levorphanol Tartrate | 11 | $41,634 |
| OxycontinOxycodone Hcl | 36 | $32,061 |
| Nurtec OdtRimegepant Sulfate | 19 | $29,271 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 376 | $11,292 |
| MovantikNaloxegol Oxalate | 28 | $10,904 |
| Oxycodone Hcl | 342 | $10,283 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 60 | $10,160 |
| Morphine Sulfate ErMorphine Sulfate | 211 | $7,621 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 163 | $6,917 |
| BelbucaBuprenorphine Hcl | 13 | $6,407 |
| Pregabalin | 174 | $6,243 |
| Buprenorphine | 27 | $5,906 |
| Ajovy SyringeFremanezumab-Vfrm | 11 | $4,892 |
| Dihydroergotamine Mesylate | 12 | $4,363 |
| Lidocaine | 38 | $4,309 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Virtus Pharmaceuticals LLCLevorphanol Tartrate | $145 | $41,63411 claims |
| PfizerNurtec Odt | $142 | $29,27119 claims |
| Redhill Biopharma Inc.Movantik | $38 | $10,90428 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $431 | $6,40713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 457 medical providers in Washington.
Other medical in Bremerton
- Vaughn HoweBremerton$4K
- Diana McFarlaneSeattle$95K
- Karissa SecoraTacoma$53K
- Tori FranklinLakewood$23K
- Salvador LopezYakima$17K
- Amy NelsonSeattle$15K
- Rebecca JohnsonSpokane$14K
- Jonathan CyphersBurien$13K
- Jonathan WhiteSeattle$13K
- Julia TaylorSpokane$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.